
Debu Tripathy, MD, MD Anderson Cancer Center
Advertisement
Articles by Debu Tripathy, MD, MD Anderson Cancer Center
Advertisement
Latest Updated Articles
Prognostic Tools for Early-Stage HER2+ Breast CancerJanuary 25th 2021
Current Treatment Landscape for HER2+ Breast CancerJanuary 25th 2021
Updated Data for Metastatic HER2+ Breast CancerJanuary 25th 2021
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Priority Review to Sonesitatug Vedotin in CLDN18.2+ Gastroesophageal Cancer
2
EC Approves Extended Cemiplimab Dosing in Skin, Lung, and Cervical Cancers
3
Dose Optimization, Evidentiary Bars, and Patient Selection Shape Trial Design in EGFR- and HER2-Mutant NSCLC
4
Defining High-Risk Localized Prostate Cancer and the DASL-HiCaP Trial
5


